1. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Issue 6 (June 2016) Authors: Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Starosławska, Elżbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia Valeria; Magazzù... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer. (October 2015) Authors: Huang, Yu-Yi; Lee, Pei-Ing; Liu, Mei-Ching; Chen, Chien-Chih; Huang, Kuo-Cheng; Huang, Andrew T. Journal: Clinical nuclear medicine Issue: Volume 40:Number 10(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer. (October 2015) Authors: Huang, Yu-Yi; Lee, Pei-Ing; Liu, Mei-Ching; Chen, Chien-Chih; Huang, Kuo-Cheng; Huang, Andrew T. Journal: Clinical nuclear medicine Issue: Volume 40:Number 10(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer. Issue 1 (December 2017) Authors: Bianchini, Giampaolo; Kiermaier, Astrid; Bianchi, Giulia; Im, Young-Hyuck; Pienkowski, Tadeusz; Liu, Mei-Ching; Tseng, Ling-Ming; Dowsett, Mitch; Zabaglo, Lila; Kirk, Sarah; Szado, Tania; Eng-Wong, Jennifer; Amler, Lukas; Valagussa, Pinuccia; Gianni, Luca Journal: Breast cancer research Issue: Volume 19:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Issue 7 (July 2018) Authors: Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Villanueva Vazquez, Rafael; Jung, Kyung Hae; Babu, K Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyu... Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗